| Brand Name | ACRYSOF IQ NATURAL SINGLEPIECE IOL |
| Common Device Name | INTRAOCULAR LENS |
| Manufacturer (Section D) |
| ALCON LABORATORIES IRELAND LTD. |
| cork business&technology park |
| model farm road |
| cork 00000 |
| EI 00000 |
|
| Manufacturer (Section G) |
| ALCON LABORATORIES IRELAND LTD. |
| cork business&technology park |
| model farm road |
| cork 00000 |
|
EI
00000
|
|
| Manufacturer Contact |
|
jonathan
schlech
|
| 6201 south freeway |
| mail stop ab2-6 |
| fort worth, TX 76134
|
|
8007579780
|
|
| MDR Report Key | 13391586 |
| Report Number | 9612169-2022-00032 |
| Device Sequence Number | 4393801 |
| Product Code |
HQL
|
| UDI-Device Identifier | 00380655093122 |
| UDI-Public | 00380655093122 |
| Combination Product (Y/N) | N |
| Initial Reporter Country | CH |
| PMA/510(K) Number | P930014 |
| Number of Events Summarized | 1 |
| Summary Report (Y/N) | N |
| Device Implanted Year | 2022 |
| Reporter Type |
Manufacturer
|
| Report Source |
Foreign,Health Professional |
| Initial Reporter Occupation |
Non-Healthcare Professional
|
| Type of Report
| Initial |
| Report Date (Section B) |
01/31/2022 |
| 1 Device was Involved in the Event |
|
| 1 Patient was Involved in the Event |
|
| Is this an Adverse Event Report? |
Yes
|
| Is this a Product Problem Report? |
No
|
| Operator of Device |
Health Professional
|
| Device Expiration Date | 11/30/2025 |
| Device Model Number | SN60WF |
| Device Catalogue Number | SN60WF.165 |
| Device Lot Number | 21291349 |
| Was Device Available for Evaluation? |
No
|
| Type of Report(Section G) | Initial |
| Initial Date Received by Manufacturer | 01/06/2022 |
| Initial Report FDA Received Date | 01/31/2022 |
| Was Device Evaluated by Manufacturer? (Y/N) |
Device Not Returned to Manufacturer
|
| Date Device Manufactured | 12/04/2020 |
Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N) |
No
|
| Usage of Device |
Initial
|
| Patient Sequence Number | 1 |
Concomitant Medical Products and Therapy/Usage Dates | DICLOFENAC SODIUM EYE DROPS; LEVOFLOXACIN HYDROCHLORIDE EYE DROPS; TOBRAMYCIN DEXAMETHASONE EYE DROPS |
| Outcome Attributed to Adverse Event |
Required Intervention;
|
| Patient Age | 48 YR |
| Patient Sex | Male |